FDA warns bayer about aspirin
The FDA has warned Bayer about its aspirin claims. According to the AP, the FDA "scolded [Bayer] in two warning letters for never submitting proof that its pills -- Bayer Women's Low Dose Aspirin + Calcium and Bayer Aspirin with Health Advantage -- are effective in battling heart disease and osteoporosis."
Janet Woodcock of the FDA's Center for Drug Evaluation and Research said that if these aspirin-containing products are overused or not used properly, consumers can be at risk for internal bleeding and other issues.
Treatments for these two diseases are required to be reviewed by a board of government scientists and cannot be sold over-the-counter.
For such "combo pills," dietary supplements and drugs, to be legally marketed, they are subject to approval and generous regulation.
What comments do you have about the weakness of the FDA and ways we might be able to improve it? Do you agree with me that potential of personal injury lawsuits provide a second line of protection for the consumers?
